Congressional CRS: Medical Cannabis Rescheduling Is a Limited Federal Opening
CRS says moving medical cannabis from Schedule I to III signals medical value and could allow some state-licensed medical cannabis businesses and researchers to operate with fewer federal barriers and may enable 280E tax deductions, but it does not fully legalize recreational marijuana or bring the entire state-legal industry into CSA compliance; many penalties remain under the CSA, and full compliance will depend on further federal action and upcoming hearings, with ongoing research and regulatory considerations plus an expedited DEA registration process for compliant medical-license holders.